GI CANCERS

Latest News

KEYNOTE-859 Outcomes Influence NCCN Guidelines on Pembrolizumab in Upper GI Cancer
KEYNOTE-859 Outcomes Influence NCCN Guidelines on Pembrolizumab in Upper GI Cancer

April 10th 2024

During a Case-Based Roundtable® event, David Zhen, MD, discussed how treatment of upper gastrointestinal cancer with pembrolizumab and chemotherapy is impacted by PD-L1 composite positive score, in the second article of a 2-part series.

Lower Radiation Levels Linked  to Poorer Tumor Response in Esophageal Cancer
Lower Radiation Levels Linked to Poorer Tumor Response in Esophageal Cancer

April 10th 2024

Rivoceranib Improves PFS, but Misses on OS in Gastric/GEJ Cancer
Rivoceranib Improves PFS, but Misses on OS in Gastric/GEJ Cancer

April 9th 2024

Neoadjuvant Atezolizumab and Chemo Show Potential in Gastric/GEJ Cancer
Neoadjuvant Atezolizumab and Chemo Show Potential in Gastric/GEJ Cancer

April 8th 2024

Zanidatamab BLA Submitted to FDA for HER2+ Biliary Tract Cancer
Zanidatamab BLA Submitted to FDA for HER2+ Biliary Tract Cancer

April 2nd 2024

More News